[go: up one dir, main page]

AU2634095A - The use of an anti-helicobacter substance - Google Patents

The use of an anti-helicobacter substance

Info

Publication number
AU2634095A
AU2634095A AU26340/95A AU2634095A AU2634095A AU 2634095 A AU2634095 A AU 2634095A AU 26340/95 A AU26340/95 A AU 26340/95A AU 2634095 A AU2634095 A AU 2634095A AU 2634095 A AU2634095 A AU 2634095A
Authority
AU
Australia
Prior art keywords
helicobacter
substance
helicobacter substance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU26340/95A
Inventor
Thomas Berglindh
Karin Meyer Rosberg
Anders Uhlin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Health AB
Original Assignee
Pharmacia AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia AB filed Critical Pharmacia AB
Publication of AU2634095A publication Critical patent/AU2634095A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7024—Esters of saccharides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU26340/95A 1994-05-27 1995-05-24 The use of an anti-helicobacter substance Abandoned AU2634095A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9401826 1994-05-27
SE9401826A SE9401826D0 (en) 1994-05-27 1994-05-27 Anti-Helicobacter pyroli substance
PCT/SE1995/000594 WO1995032717A1 (en) 1994-05-27 1995-05-24 The use of an anti-helicobacter substance

Publications (1)

Publication Number Publication Date
AU2634095A true AU2634095A (en) 1995-12-21

Family

ID=20394147

Family Applications (1)

Application Number Title Priority Date Filing Date
AU26340/95A Abandoned AU2634095A (en) 1994-05-27 1995-05-24 The use of an anti-helicobacter substance

Country Status (3)

Country Link
AU (1) AU2634095A (en)
SE (1) SE9401826D0 (en)
WO (1) WO1995032717A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5660842A (en) * 1994-10-04 1997-08-26 Bristol-Myers Squibb Company Inhibition of helicobacter
DE19812661A1 (en) * 1998-03-23 2000-09-28 Aventis Res & Tech Gmbh & Co Sucrose-N-alkyl asparaginates, their preparation and use
WO2009049370A1 (en) * 2007-10-16 2009-04-23 Progen Pharmaceuticals Limited Novel sulfated oligosaccharide derivatives

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK505488D0 (en) * 1987-12-21 1988-09-09 Bar Shalom Daniel MEDIUM AND USE OF SAME
US4935406A (en) * 1988-09-20 1990-06-19 Marion Laboratories, Inc. Use of bismuth (phosph/sulf)ated saccharides against Camplyobacter-associated gastrointestinal disorders
WO1992003453A1 (en) * 1990-08-23 1992-03-05 Dainippon Ink & Chemicals, Inc. Antiviral agent
US5116821A (en) * 1990-11-20 1992-05-26 The Procter & Gamble Company Sulfated glyceroglucolipids as inhibitors of bacterial adherence
AU4993893A (en) * 1992-07-31 1994-03-03 Neose Pharmaceuticals, Inc. Compositions for treating and inhibiting gastric and duodenal ulcers

Also Published As

Publication number Publication date
SE9401826D0 (en) 1994-05-27
WO1995032717A1 (en) 1995-12-07

Similar Documents

Publication Publication Date Title
AU6709596A (en) Amide compounds and use of the same
AU3811495A (en) Antibodies
AU9790198A (en) Compounds and methods
AU2734895A (en) Process for the preparation of 3-aryluracils
AU2448797A (en) Methods of providing neuroprotection
AU2424895A (en) Substituted spirodienes for the treatment of inflammation
AU5923998A (en) 2-benzoylamino-3-phenylpropenamide derivatives and methods of using the same
AU4224096A (en) Use of phenylcyclohexylcarboxamides
AU2682895A (en) EG Cells of Ungulates
AU1963395A (en) Boom-structure
AU3783097A (en) Process for the preparation of hexanitrohexaazaisowurtzitanes
AU4712696A (en) The use of heterocyclic compounds
AU4505996A (en) 7-vinylidene cephalosporins and methods of using the same
AU2634095A (en) The use of an anti-helicobacter substance
AU4250296A (en) Curler
AU1289695A (en) Human stanniocalcin-alpha
AU1207497A (en) Process for the preparation of para-fluorophenol
AU7974798A (en) New human lysophospholipase
AU4708697A (en) Process for the preparation of eberconazol and intermediates thereof
AU1587295A (en) The treatment of gaseous substances
AU1603595A (en) Meso-azanoradamantanes
AU2937795A (en) Crutch
AU2671895A (en) Bisquinolines for the treatment of malaria
AU7172098A (en) Human lysophospholipase
AU2797395A (en) Method for the manufacture of halogenoalcanols